We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.9B
AUM Growth
-$199M
Cap. Flow
-$157M
Cap. Flow %
-2.27%
Top 10 Hldgs %
24.04%
Holding
3,083
New
373
Increased
407
Reduced
1,584
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 23.96%
2 Healthcare 12.46%
3 Financials 12.39%
4 Consumer Discretionary 12.33%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AERI
2351
DELISTED
Aerie Pharmaceuticals
AERI
$134K ﹤0.01%
11,782
ERAS icon
2352
Erasca
ERAS
$6.25B
$134K ﹤0.01%
+6,325
New +$130K
VRS
2353
DELISTED
Verso Corporation
VRS
$134K ﹤0.01%
6,451
-2,343
-27% -$45.2K
AMTX icon
2354
Aemetis
AMTX
$126M
$133K ﹤0.01%
+7,302
New +$80.7K
DCO icon
2355
Ducommun
DCO
$3.01B
$133K ﹤0.01%
2,650
-950
-26% -$49.8K
BFC icon
2356
Bank First Corp
BFC
$1.76B
$133K ﹤0.01%
1,881
MSGS icon
2357
Madison Square Garden
MSGS
$9.94B
$133K ﹤0.01%
716
-25
-3% -$4.28K
STWD icon
2358
Starwood Property Trust
STWD
$6.05B
$133K ﹤0.01%
5,454
-219
-4% -$5.6K
RGP icon
2359
Resources Connection
RGP
$145M
$133K ﹤0.01%
8,434
+4,091
+94% +$61.5K
FCBC icon
2360
First Community Bankshares
FCBC
$933M
$133K ﹤0.01%
4,186
-1,607
-28% -$48.6K
SPNE
2361
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$133K ﹤0.01%
8,432
DHIL
2362
DELISTED
Diamond Hill
DHIL
$132K ﹤0.01%
754
-260
-26% -$45.5K
IMXI icon
2363
International Money Express
IMXI
$353M
$132K ﹤0.01%
7,924
CUE icon
2364
Cue Biopharma
CUE
$131M
$132K ﹤0.01%
303
+10
+3% +$3.49K
AMRX icon
2365
Amneal Pharmaceuticals
AMRX
$6.02B
$131K ﹤0.01%
24,559
-9,436
-28% -$47.5K
XPRO icon
2366
Expro Ltd
XPRO
$2.1B
$131K ﹤0.01%
+7,423
New +$126K
CNXN icon
2367
PC Connection
CNXN
$2.04B
$131K ﹤0.01%
2,973
TPC
2368
Tutor Perini Cor
TPC
$4.98B
$131K ﹤0.01%
10,083
+2,414
+31% +$33K
VLDR
2369
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$130K ﹤0.01%
22,010
VUZI icon
2370
Vuzix
VUZI
$220M
$130K ﹤0.01%
12,428
-3,956
-24% -$52.9K
BXC icon
2371
BlueLinx
BXC
$705M
$130K ﹤0.01%
2,659
DMRC icon
2372
Digimarc Corp
DMRC
$158M
$130K ﹤0.01%
3,771
SPRO icon
2373
Spero Therapeutics
SPRO
$71.8M
$129K ﹤0.01%
6,987
EQBK icon
2374
Equity Bancshares
EQBK
$1.07B
$129K ﹤0.01%
3,852
-1,517
-28% -$47.4K
MTUS icon
2375
Metallus
MTUS
$892M
$128K ﹤0.01%
9,822
-3,540
-26% -$48.5K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 Portfolio in Review

As of Q3 2021, Metropolitan Life Insurance Company (MetLife) held 3,083 positions worth $6.9B, down 2.8% from $7.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 filing shows 373 new, 407 increased, 1,584 reduced and 241 closed positions. Its largest new stake was Alphabet (Google) Class C: 878,340 shares worth $117M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2021 buy was Alphabet (Google) Class C: 878,340 shares worth $117M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $17.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $6.9B portfolio in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 373 new positions and closed 241 in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 2.8% quarter-over-quarter to $6.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.